Abstract:Mediator of IRF3 activation (MITA, also known as stimulator of interferon genes, STING) senses the second messenger cyclic GMP-AMP (cGAMP) which is synthesized upon DNA virus infection and activates innate antiviral immune response. It has been demonstrated that the activity of MITA is delicately regulated by various post-translational modifications including polyubiquitination. In this study, we identified the deubiquitinating enzyme USP44 as a positive regulator of MITA. USP44 is recruited to MITA following DNA virus infection and removes K48-linked polyubiquitin moieties from MITA at K236, therefore prevents MITA from proteasome mediated degradation. USP44-deficiency results in acceleration of HSV-1-induced degradation of MITA and reduced induction of type I interferons (IFNs) and proinflammatory cytokines. Consistently, Usp44-/- mice are more susceptible to HSV-1 infection as indicated by higher tissue viral titers, greater tissue damage and lower survival rate. These findings suggest that USP44 plays a specific and critical role in the regulation of innate immune response against DNA viruses.Cyclic GMP-AMP synthase (cGAS) senses cytosolic dsDNA and initiates signal transductions, leading to activation of innate immune response. MITA is the key adaptor protein downstream of cGAS and plays a critical role in cGAS-mediated signaling. The activity of MITA is tightly regulated by various post-translational modifications including polyubiquitination and deubiquitination. Here we found that the deubiquitinating enzymes USP44 associates with MITA and removes the K48-linked polyubiquitin chains from MITA, therefore maintains the stability of MITA after DNA virus infection. Deficiency of USP44 results in accelerated degradation of MITA, impaired induction of type I IFNs and proinflammatory cytokines, and increased viral replication. These findings suggest that USP44 is a positive regulator of MITA and plays an important role in the regulation of innate immune response against DNA viruses.

USP21 Negatively Regulates Antiviral Response by Acting As a RIG-I Deubiquitinase

Ubiquitin-specific Protease 15 Negatively Regulates Virus-induced Type I Interferon Signaling via Catalytically-dependent and -independent Mechanisms

Usp4 Positively Regulates Rig-I-Mediated Antiviral Response Through Deubiquitination and Stabilization of Rig-I

Deubiquitinase USP47 attenuates virus-induced type I interferon signaling

USP3 Inhibits Type I Interferon Signaling by Deubiquitinating RIG-I-like Receptors

USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS

Ubiquitin-specific proteases 25 negatively regulates virus-induced type I interferon signaling.

E3 Ligase FBXW7 is Critical for RIG-I Stabilization During Antiviral Responses

USP22 Promotes IRF3 Nuclear Translocation and Antiviral Responses by Deubiquitinating the Importin Protein KPNA2

The Ubiquitin-Specific Protease 17 is Involved in Virus-Triggered Type I IFN Signaling

USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA

USP13 negatively regulates antiviral responses by deubiquitinating STING

Ubiquitin Specific Protease 5 Negatively Regulates the IFNs-mediated Antiviral Activity Via Targeting SMURF1.

USP7-TRIM27 Axis Negatively Modulates Antiviral Type I IFN Signaling.

USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA

USP20 Promotes Cellular Antiviral Responses via Deconjugating K48-Linked Ubiquitination of MITA

USP26 suppresses type I interferon signaling by targeting TRAF3 for deubiquitination

Deubiquitinase USP2a Sustains Interferons Antiviral Activity by Restricting Ubiquitination of Activated STAT1 in the Nucleus

USP49 negatively regulates cellular antiviral responses via deconjugating K63-linked ubiquitination of MITA

Usp19 Modulates Autophagy and Antiviral Immune Responses by Deubiquitinating Beclin-1

USP1-UAF1 Deubiquitinase Complex Stabilizes TBK1 and Enhances Antiviral Responses